STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Side Effects of Pulmonary Hypertension Medications

Completed

Conditions: Pulmonary Hypertension

First Posted Date: 2012-04-05

Last Posted Date: 2021-09-16

Lead Sponsor: Stanford University

Target Recruit Count: 250

Registration Number: NCT01571713

Locations: 🇺🇸
Lucile Packard Children's Hospital at Stanford, Stanford, California, United States

Investigation of Dysynchrony in Patients With Pulmonary Hypertension

Conditions: Pulmonary Hypertension

Interventions: Procedure: Catheterization Pacing

First Posted Date: 2012-04-05

Last Posted Date: 2024-12-19

Lead Sponsor: Stanford University

Target Recruit Count: 100

Registration Number: NCT01571700

Locations: 🇺🇸
Stanford Hospital, Stanford, California, United States

Tap Water Versus Normal Saline for Wound Irrigation

Not Applicable

Completed

Conditions: Wound Infection Rate

Interventions: Procedure: wound irrigation with study fluid

First Posted Date: 2012-03-27

Last Posted Date: 2012-03-27

Lead Sponsor: Stanford University

Target Recruit Count: 660

Registration Number: NCT01564342

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States

Pioglitazone in Patients With Mood Disorders

Phase 4

Completed

Conditions: Insulin Resistance
Major Depressive Disorder

Interventions: Drug: Sugar Pill
Drug: Pioglitazone

First Posted Date: 2012-03-21

Last Posted Date: 2017-05-10

Lead Sponsor: Stanford University

Target Recruit Count: 37

Registration Number: NCT01559857

Locations: 🇺🇸
Stanford University Department of Psychiatry & Behavioral Sciences, Palo Alto, California, United States

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Terminated

Conditions: Other Skin Disorders
Mycosis Fungoides
Cutaneous T-cell Lymphoma
Cutaneous Lymphoma

First Posted Date: 2012-03-16

Last Posted Date: 2016-06-24

Lead Sponsor: Stanford University

Target Recruit Count: 70

Registration Number: NCT01556828

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Assessment of Patient Experience During Treatment for Cancer

Completed

Conditions: Carcinoma

First Posted Date: 2012-03-14

Last Posted Date: 2020-04-29

Lead Sponsor: Stanford University

Target Recruit Count: 116

Registration Number: NCT01553825

Locations: 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States

Early Screening and Treatment of Women With Prediabetes in Pregnancy

Not Applicable

Completed

Conditions: Diabetes
Pregnancy

Interventions: Other: Treatment for glucose intolerance
Other: Minimum intervention control group

First Posted Date: 2012-03-13

Last Posted Date: 2019-01-16

Lead Sponsor: Stanford University

Target Recruit Count: 95

Registration Number: NCT01552213

Locations: 🇺🇸
Santa Clara Valley Medical Center, San Jose, California, United States
🇺🇸
Stanford University School of Medicine/Lucile Packard Childrens Hospital, Stanford, California, United States

Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study

Completed

Conditions: Prostate Cancer

Interventions: Device: Hand held transrectal Combined Ultrasound and photoacoustic imaging (PAI) probe

First Posted Date: 2012-03-12

Last Posted Date: 2021-11-02

Lead Sponsor: Stanford University

Target Recruit Count: 20

Registration Number: NCT01551576

Locations: 🇺🇸
Stanford University Cancer Institute, Stanford, California, United States

Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation

Not Applicable

Completed

Conditions: Insulin Resistance
Hypertension
Hyperlipidemia
Obesity

Interventions: Dietary Supplement: N-Acetylcysteine
Other: Placebo
Dietary Supplement: Glutathione

First Posted Date: 2012-03-12

Last Posted Date: 2023-02-21

Lead Sponsor: Stanford University

Target Recruit Count: 78

Registration Number: NCT01550432

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

Not Applicable

Completed

Conditions: Opioid Withdrawal
Physical Dependence

Interventions: Drug: Ondansetron
Drug: Placebo
Drug: Morphine
Drug: Naloxone 0.4 mg/70 kg
Drug: Naloxone 0.8 mg/70 kg

First Posted Date: 2012-03-09

Last Posted Date: 2019-01-07

Lead Sponsor: Stanford University

Target Recruit Count: 133

Registration Number: NCT01549652

Locations: 🇺🇸
Stanford University, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy